{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,22]],"date-time":"2025-11-22T16:31:18Z","timestamp":1763829078532,"version":"3.40.5"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","internationaljournalofcardiology.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.ijcard.2016.08.224","type":"journal-article","created":{"date-parts":[[2016,8,15]],"date-time":"2016-08-15T09:44:31Z","timestamp":1471254271000},"page":"619-624","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Aspirin and renal insufficiency progression in patients with atrial fibrillation and chronic kidney disease"],"prefix":"10.1016","volume":"223","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6357-5213","authenticated-orcid":false,"given":"Daniele","family":"Pastori","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pasquale","family":"Pignatelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Perticone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela","family":"Sciacqua","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Carnevale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7104-5826","authenticated-orcid":false,"given":"Alessio","family":"Farcomeni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefania","family":"Basili","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gino R.","family":"Corazza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Dav\u00ec","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory Y.H.","family":"Lip","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6610-7068","authenticated-orcid":false,"given":"Francesco","family":"Violi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2016.08.224_bb0005","doi-asserted-by":"crossref","first-page":"F1","DOI":"10.1152\/ajprenal.2001.281.1.F1","article-title":"Physiological regulation of cyclooxygenase-2 in the kidney","volume":"281","author":"Harris","year":"2001","journal-title":"Am. J. Physiol. Renal Physiol."},{"issue":"Suppl. 1","key":"10.1016\/j.ijcard.2016.08.224_bb0010","first-page":"SI53","article-title":"Renal effects of nonselective NSAIDs and coxibs","volume":"69","author":"Weir","year":"2002","journal-title":"Cleve. Clin. J. Med."},{"key":"10.1016\/j.ijcard.2016.08.224_bb0015","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.plefa.2003.12.021","article-title":"Thromboxane blockade reduces blood pressure and progression of renal failure independent of endothelin-1 in uremic rats","volume":"71","author":"Lariviere","year":"2004","journal-title":"Prostaglandins Leukot. Essent. Fat. Acids"},{"key":"10.1016\/j.ijcard.2016.08.224_bb0020","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0735-1097(03)00511-4","article-title":"Thromboxane inhibition improves renal perfusion and excretory function in severe congestive heart failure","volume":"42","author":"Castellani","year":"2003","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2016.08.224_bb0025","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1056\/NEJM198902163200703","article-title":"Improvement of renal function with selective thromboxane antagonism in lupus nephritis","volume":"320","author":"Pierucci","year":"1989","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2016.08.224_bb0030","doi-asserted-by":"crossref","first-page":"2800","DOI":"10.1161\/01.CIR.0000039528.49161.E9","article-title":"Increased oxidative stress and platelet activation in patients with hypertension and renovascular disease","volume":"106","author":"Minuz","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2016.08.224_bb0035","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.ejim.2015.02.018","article-title":"Brain and kidney, victims of atrial microembolism in elderly hospitalized patients? Data from the REPOSI study","volume":"26","author":"Corrao","year":"2015","journal-title":"Eur. J. Intern. Med."},{"key":"10.1016\/j.ijcard.2016.08.224_bb0040","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1161\/CIRCEP.110.957100","article-title":"Association of chronic kidney disease with atrial fibrillation among adults in the United States: REasons for Geographic and Racial Differences in Stroke (REGARDS) study","volume":"4","author":"Baber","year":"2011","journal-title":"Circ. Arrhythm. Electrophysiol."},{"key":"10.1016\/j.ijcard.2016.08.224_bb0045","doi-asserted-by":"crossref","first-page":"4678","DOI":"10.1016\/j.ijcard.2013.07.179","article-title":"Sequential changes in renal function and the risk of stroke and death in patients with atrial fibrillation","volume":"168","author":"Guo","year":"2013","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ijcard.2016.08.224_bb0050","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.ahj.2015.05.011","article-title":"Urinary 11-dehydro-thromboxane B2 is associated with cardiovascular events and mortality in patients with atrial fibrillation","volume":"170","author":"Pastori","year":"2015","journal-title":"Am. Heart J."},{"key":"10.1016\/j.ijcard.2016.08.224_bb0055","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/j.jacc.2010.02.068","article-title":"Aspirin is beneficial in hypertensive patients with chronic kidney disease: a post-hoc subgroup analysis of a randomized controlled trial","volume":"56","author":"Jardine","year":"2010","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2016.08.224_bb0060","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1177\/107602960100700111","article-title":"A comparison of every-third-day versus daily low-dose aspirin therapy on serum thromboxane concentrations in healthy men and women","volume":"7","author":"Feldman","year":"2001","journal-title":"Clin. Appl. Thromb. Hemost."},{"key":"10.1016\/j.ijcard.2016.08.224_bb0065","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/0049-3848(80)90066-3","article-title":"Low dose aspirin and inhibition of thromboxane B2 production in healthy subjects","volume":"17","author":"Patrono","year":"1980","journal-title":"Thromb. Res."},{"key":"10.1016\/j.ijcard.2016.08.224_bb0070","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2015-008026","article-title":"Relationship between low ankle-brachial index and rapid renal function decline in patients with atrial fibrillation: a prospective multicentre cohort study","volume":"5","author":"Violi","year":"2015","journal-title":"BMJ Open"},{"key":"10.1016\/j.ijcard.2016.08.224_bb0075","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1056\/NEJM198402023100502","article-title":"Effects of sulindac and ibuprofen in patients with chronic glomerular disease. Evidence for the dependence of renal function on prostacyclin","volume":"310","author":"Ciabattoni","year":"1984","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2016.08.224_bb0080","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1016\/j.ehj.2004.07.013","article-title":"Drug evaluation in atherosclerotic vascular disease in diabetics study G. Picotamide, a combined inhibitor of thromboxane A2 synthase and receptor, reduces 2-year mortality in diabetics with peripheral arterial disease: the DAVID study","volume":"25","author":"Neri Serneri","year":"2004","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2016.08.224_bb0085","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/j.amjcard.2012.12.045","article-title":"Renal impairment in a \u201creal-life\u201d cohort of anticoagulated patients with atrial fibrillation (implications for thromboembolism and bleeding)","volume":"111","author":"Roldan","year":"2013","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ijcard.2016.08.224_bb0090","doi-asserted-by":"crossref","first-page":"9G","DOI":"10.1016\/S0002-9149(03)00227-3","article-title":"Atrial fibrillation: hypertension as a causative agent, risk factor for complications, and potential therapeutic target","volume":"91","author":"Healey","year":"2003","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ijcard.2016.08.224_bb0095","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/nrneph.2015.114","article-title":"Management of hypertension in chronic kidney disease","volume":"11","author":"Townsend","year":"2015","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.ijcard.2016.08.224_bb0100","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1161\/01.HYP.0000112225.27560.24","article-title":"Role for thromboxane receptors in angiotensin-II-induced hypertension","volume":"43","author":"Francois","year":"2004","journal-title":"Hypertension"}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527316319313?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527316319313?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,3,22]],"date-time":"2019-03-22T23:56:54Z","timestamp":1553299014000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527316319313"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":20,"alternative-id":["S0167527316319313"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2016.08.224","relation":{},"ISSN":["0167-5273"],"issn-type":[{"type":"print","value":"0167-5273"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Aspirin and renal insufficiency progression in patients with atrial fibrillation and chronic kidney disease","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2016.08.224","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}